Consilience Ventures

Cerebreon Technologies Ltd., founded in 2016 and headquartered in Portnoo, Ireland, specializes in developing software solutions for the insolvency market. The company focuses on advanced data analytics, business management systems, and process automation. Its software is designed to enhance debt recovery processes by utilizing machine learning and smart analytics to predict outcomes and improve operational efficiency. By identifying potential customer defaults early, Cerebreon's solutions help creditors and insolvency practitioners take preventative action, thereby reducing costs and ensuring compliance. The company aims to make high-end analytics accessible to businesses of all sizes and sectors, providing tailored software solutions and expert consultancy services.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

Jiva.ai is an innovative no-code platform that enables users across various industries to create, evaluate, and deploy autonomous AI agents without requiring programming skills. Focused on democratizing AI technology, Jiva.ai supports multimodal AI, allowing the integration of diverse data types such as imaging, voice, and text. This capability facilitates its application in sectors like healthcare, where it has been instrumental in developing high-fidelity diagnostics and improving clinical outcomes. The platform excels in rapidly prototyping and deploying AI models, significantly reducing the time and expertise typically needed for AI development. Jiva.ai's advancements in agentic AI empower systems to autonomously manage tasks, including supply chain monitoring and customer support, addressing the increasing demand for intelligent systems. The company has received multiple awards for its contributions to AI and has partnered with notable organizations like MongoDB and IBM HyperProtect as part of its growth strategy.

Sime Diagnostics Ltd is a clinical AI platform company that specializes in neonatal healthcare, offering innovative solutions to improve patient outcomes in critical care settings. Founded in 2014 and based in London, the company has developed a proprietary software that provides data-driven insights to healthcare professionals, particularly in the neonatal intensive care unit. Their flagship product, the Lung Maturity Test (LMT), predicts Respiratory Distress Syndrome (RDS) in premature infants, allowing for timely interventions that can significantly reduce morbidity and mortality rates. The platform not only aids in real-time disease detection but also curates unique datasets for biomarker discovery, which can benefit both the company and its commercial partners across various medical fields. With a commitment to preventative, personalized medicine, Sime Diagnostics aims to enhance the quality of care through its advanced AI technologies.

Cerebreon Technologies Ltd., founded in 2016 and headquartered in Portnoo, Ireland, specializes in developing software solutions for the insolvency market. The company focuses on advanced data analytics, business management systems, and process automation. Its software is designed to enhance debt recovery processes by utilizing machine learning and smart analytics to predict outcomes and improve operational efficiency. By identifying potential customer defaults early, Cerebreon's solutions help creditors and insolvency practitioners take preventative action, thereby reducing costs and ensuring compliance. The company aims to make high-end analytics accessible to businesses of all sizes and sectors, providing tailored software solutions and expert consultancy services.